Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials

BACKGROUND: Exploratory analysis to determine the effect of semaglutide versus comparators on high-sensitivity C-reactive protein (hsCRP) in subjects with type 2 diabetes. METHODS: Trials of once-weekly subcutaneous (SUSTAIN 3) and once-daily oral (PIONEER 1, 2, 5) semaglutide with hsCRP data were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosenzon, Ofri, Capehorn, Matthew S., De Remigis, Alessandra, Rasmussen, Søren, Weimers, Petra, Rosenstock, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440529/
https://www.ncbi.nlm.nih.gov/pubmed/36056351
http://dx.doi.org/10.1186/s12933-022-01585-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440529/
https://www.ncbi.nlm.nih.gov/pubmed/36056351
http://dx.doi.org/10.1186/s12933-022-01585-7

Ejemplares similares